Compare Antimicrobial to Conventional Suture in Patients Receiving Primary Total Knee Replacement
Vicryl-Plus
Compare the Results of Antimicrobial to Conventional Suture Materials in Patients Receiving Primary Total Knee Replacement: A Prospective Double-blinded Randomized Controlled Trial
1 other identifier
interventional
102
1 country
1
Brief Summary
Total knee replacement is now one of the most popular reconstructive procedures for the elderly people to regain their functional capacity and life quality. However the reported incidence of postoperative infection or surgical site infection after total knee replacement has been around 1 to 2 percent. The cost and expenditure for treating periprosthetic infection are high and the results are often detrimental to the patients who suffered from the complication. To decrease the wound healing complication related to the contamination of bacteria, an antibacterial suture was used successfully in some clinical settings and in animal experiments. Whether the antibacterial suture material could be used in patients with total knee replacement has not been addressed in the past. The investigators therefore propose a prospective randomized double-blinded study to investigate the efficacy of an antibacterial suture material in total knee replacement. The inclusion criteria are patients with degenerative osteoarthritis without previous surgery to the index knee. Patients who have inflammatory arthritis such as rheumatoid arthritis, who have neurovascular disease of the lower extremities, who have history of liver cirrhosis or under hemodialysis for renal failure are excluded. One hundred and two patients will be randomized to study group (51 knees) and control group (51 knees) in a period of 12 months. All cases will follow the standard protocol based on clinical pathway. Antibacterial suture material (Vicryl Plus, Ethicon) will be used in the study group and regular suture material (Vicryl, Ethicon) will be used in the control group. Preoperatively, the skin condition (digital photo and image analysis),laser Doppler study, inflammatory markers (CRP/ESR/IL-6), functional score (KSS: Knee Society Score; SF-12: Short Form 12), and VAS score will be assessed. Operative data of operation time, blood loss and wound classification are recorded. Postoperatively, the skin condition (digital photo and image analysis), skin temperature, inflammatory markers, KSS, and VAS will be assessed on 1st and 3rd postoperative day, 2 weeks, 4 weeks, and 3 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jun 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 20, 2015
CompletedFirst Posted
Study publicly available on registry
August 26, 2015
CompletedAugust 26, 2015
August 1, 2015
1.5 years
August 20, 2015
August 24, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
wound infection
3 months
Secondary Outcomes (1)
serum inflammatory marker
3 months
Other Outcomes (1)
Physiological parameter (skin temperature)
3 months
Study Arms (2)
Vicryl
ACTIVE COMPARATORVicryl suture for wound closure after total knee replacement
vicryl plus
EXPERIMENTALVicryl plus suture for wound closure after total knee replacement
Interventions
wound closure with vicryl plus suture
Eligibility Criteria
You may qualify if:
- Degenerative osteoarthritis
- Any age
- Varus/valgus deformity knee
You may not qualify if:
- Inflammatory arthritis
- Systemic diseases with coagulopathy
- Immune compromise(ESRD, liver cirrhosis)
- PAOD or DVT history
- Pre-OP INR \>1.5
- ASA score \>3
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mel Shiuann-Sheng Leelead
- Johnson & Johnsoncollaborator
Study Sites (1)
Chang Gung Memorial Hospital
Kweishan, Taoyuan, 333, Taiwan
Related Publications (2)
Rozzelle CJ, Leonardo J, Li V. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr. 2008 Aug;2(2):111-7. doi: 10.3171/PED/2008/2/8/111.
PMID: 18671615BACKGROUNDLin SJ, Chang FC, Huang TW, Peng KT, Shih HN, Lee MS. Temporal Change of Interleukin-6, C-Reactive Protein, and Skin Temperature after Total Knee Arthroplasty Using Triclosan-Coated Sutures. Biomed Res Int. 2018 Jan 15;2018:9136208. doi: 10.1155/2018/9136208. eCollection 2018.
PMID: 29568771DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Chang Gung Memorial Hospital, Dept Orthopedic Surgery
Study Record Dates
First Submitted
August 20, 2015
First Posted
August 26, 2015
Study Start
June 1, 2011
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
August 26, 2015
Record last verified: 2015-08